相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of alternative splicing of the receptor for advanced glycation endproducts (RAGE) through G-rich cis-elements and heterogenous nuclear ribonucleoprotein H
Kazuyo Ohe et al.
JOURNAL OF BIOCHEMISTRY (2010)
sRAGE Induces Human Monocyte Survival and Differentiation
Yijie Wang et al.
JOURNAL OF IMMUNOLOGY (2010)
Association between the RAGE G82S polymorphism and Alzheimer's disease
Keshen Li et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
RAGE Gene Polymorphisms Are Associated with Circulating Levels of Endogenous Secretory RAGE but Not with Coronary Artery Disease in Chinese Patients with Type 2 Diabetes Mellitus
Wen Hui Peng et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease
Ling Zhang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene
Anastasia Z. Kalea et al.
FASEB JOURNAL (2009)
Association of Polymorphism in the Receptor for Advanced Glycation End Products (RAGE) Gene with Circulating RAGE Levels
Katrien H. J. Gaens et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease
Andrew M. Smith et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Revisiting Crohn's disease as a primary immunodeficiency of macrophages
Jean-Laurent Casanova et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer
Jan M. Ehrchen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Association Between Serum Levels of the Soluble Receptor (sRAGE) for Advanced Glycation Endproducts (AGEs) and their Receptor (RAGE) in Peripheral Blood Mononuclear Cells of Children with Type 1 Diabetes Mellitus
Athina Dettoraki et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2009)
Low levels of plasma soluble receptor for advanced glycation end products are associated with severe leukoaraiosis in acute stroke patients
Chiaki Yokota et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis
Yueh-Sheng Chen et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury
Haiying Zhang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases
Ling Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells
Georg Varga et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease
D. Foell et al.
JOURNAL OF PATHOLOGY (2008)
Acute Kawasaki disease is associated with reverse regulation of with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12
Helmut Wittkowski et al.
ARTHRITIS AND RHEUMATISM (2007)
Mechanisms of Disease: a 'DAMP' view of inflammatory arthritis
Dirk Foell et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome
Helmut Wittkowski et al.
CRITICAL CARE MEDICINE (2007)
DLG5 R30Q variant is a female-specific protective factor in pediatric onset Crohn's disease
Vincent Biank et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes
Jan Ehrchen et al.
BLOOD (2007)
The-374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients
Geraldo Picheth et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)
The-374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients
E. Lindholm et al.
DIABETOLOGIA (2006)
Understanding RAGE, the receptor for advanced glycation end products
A Bierhaus et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Carboxylated glycans mediate colitis through activation of NF-κB
G Srikrishna et al.
JOURNAL OF IMMUNOLOGY (2005)
The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study
MA Hofmann et al.
ATHEROSCLEROSIS (2005)
Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs
CM Cheng et al.
MODERN PATHOLOGY (2005)
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension
D Geroldi et al.
JOURNAL OF HYPERTENSION (2005)
Bacterial interactions with cells of the intestinal mucosa: toll-like receptors and NOD2
E Cario
GUT (2005)
Defects in mucosal immunity leading to Crohn's disease
GM Cobrin et al.
IMMUNOLOGICAL REVIEWS (2005)
The-374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes
KG dos Santos et al.
MOLECULAR GENETICS AND METABOLISM (2005)
Sargramostim for active Crohn's disease
JR Korzenik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men
C Falcone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
High-mobility group box 1 protein (HMGB): Nuclear weapon in the immune arsenal
MT Lotze et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Haploview: analysis and visualization of LD and haplotype maps
JC Barrett et al.
BIOINFORMATICS (2005)
Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control
R Pullerits et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
B Liliensiek et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Genetic variation in DLG5 is associated with inflammatory bowel disease
M Stoll et al.
NATURE GENETICS (2004)
The immunological and genetic basis of inflammatory bowel disease
G Bouma et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease
D Foell et al.
GUT (2003)
The functional-374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients
K Pettersson-Fernholm et al.
DIABETES (2003)
RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response
MA Hofmann et al.
GENES AND IMMUNITY (2002)
A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics
WH Liu et al.
ANALYTICAL BIOCHEMISTRY (2002)
Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM
K Kañková et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2001)
Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy
BI Hudson et al.
DIABETES (2001)
分享论文
